- Home
- SNGX vs IVDA Comparison
SNGX vs IVDA Comparison
Compare SNGX & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- IVDA
- Stock Information
- Founded
- SNGX 1987
- IVDA 2003
- Country
- SNGX United States
- IVDA United States
- Employees
- SNGX N/A
- IVDA N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- IVDA Computer Software: Prepackaged Software
- Sector
- SNGX Health Care
- IVDA Technology
- Exchange
- SNGX Nasdaq
- IVDA Nasdaq
- Market Cap
- SNGX 9.6M
- IVDA 9.3M
- IPO Year
- SNGX 1987
- IVDA N/A
- Fundamental
- Price
- SNGX $3.16
- IVDA $3.17
- Analyst Decision
- SNGX
- IVDA
- Analyst Count
- SNGX 0
- IVDA 0
- Target Price
- SNGX N/A
- IVDA N/A
- AVG Volume (30 Days)
- SNGX 46.1K
- IVDA 598.8K
- Earning Date
- SNGX 11-08-2024
- IVDA 11-14-2024
- Dividend Yield
- SNGX N/A
- IVDA N/A
- EPS Growth
- SNGX N/A
- IVDA N/A
- EPS
- SNGX N/A
- IVDA N/A
- Revenue
- SNGX $364,183.00
- IVDA $5,305,155.00
- Revenue This Year
- SNGX N/A
- IVDA $23.76
- Revenue Next Year
- SNGX $76.64
- IVDA $229.89
- P/E Ratio
- SNGX N/A
- IVDA N/A
- Revenue Growth
- SNGX N/A
- IVDA N/A
- 52 Week Low
- SNGX $1.83
- IVDA $1.27
- 52 Week High
- SNGX $19.20
- IVDA $10.16
- Technical
- Relative Strength Index (RSI)
- SNGX 41.70
- IVDA 70.54
- Support Level
- SNGX $2.93
- IVDA $1.93
- Resistance Level
- SNGX $3.35
- IVDA $2.16
- Average True Range (ATR)
- SNGX 0.19
- IVDA 0.38
- MACD
- SNGX -0.01
- IVDA 0.14
- Stochastic Oscillator
- SNGX 37.10
- IVDA 65.45
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).